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Meiotic origin of trisomy in neoplasms: evidence in a case of erythroleukaemia
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Trisomic cells in neoplasms may represent abnormal clones
originated from a tissue-confined mosaicism, and arise there-
fore by a meiotic error. We report on a 16-month-old child with
erythroleukaemia (AML-M6), whose marrow karyotype at onset
was 48,XX,del(13)(q12q14),del(14)(q22q32),+21,+21. The par-
ental origin of the supernumerary chromosomes 21 was inves-
tigated by comparing 10 polymorphic loci scattered along the
whole chromosome on the patient’s marrow and her parents’
leukocytes. Three loci were informative for the presence of
three alleles, two of which were of maternal origin; two further
loci showed a maternal allele of higher intensity. Lymphocytes
and skin fibroblasts showed a normal karyotype, and molecular
analysis on leukocytes at remission, buccal smear and urinary
sediment cells consistently showed only one maternal allele,
whereas neonatal blood from Guthrie spot showed two
maternal alleles as in the marrow. An accurate clinical re-evalu-
ation confirmed a normal phenotype. Our results indicate that
tetrasomy 21 arose from a marrow clone with trisomy 21 of mei-
otic origin. To the best of our knowledge, this is the first evi-
dence that supernumerary chromosomes in neoplastic clones
may in fact be present due to a meiotic error. This demon-
strates that a tissue-confined constitutional mosaicism for a
trisomy may indeed represent the first event in multistep
carcinogenesis. Leukemia (2001) 15, 971–975.
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Introduction
Trisomies are frequent in neoplasms: they often are the only
chromosome anomaly present at onset in neoplastic clones,1
and are therefore regarded as primary changes in their patho-
genesis. This is true in particular for haematological malig-
nancies, in which some trisomies are so frequent in a disease
or a disease phase, that they certainly play a specific patho-
genetic role:2 this is the case of trisomy 8 in acute myeloid
leukaemias (AML) or trisomies 8 and 19 in the blastic phase
of chronic myelocytic leukaemia (CML). In 1993, Haas and
Seyger3 postulated that some of these trisomies represent evi-
dence of tissue-confined residual cell populations of meiotic
origin. This hypothesis was based on circumstantial evidence,
and raised some interest,4–6 but it was never supported by any
direct evidence.
We report on a child with erythroleukaemia associated with
tetrasomy 21, in which microsatellite analysis gave evidence
of the meiotic origin of one supernumerary chromosome 21
in the marrow, supporting the hypothesis mentioned above,
and in the absence of clinical signs of Down syndrome (DS).
We failed to obtain evidence of a trisomic cell population
with cytogenetic and molecular methods in other available
tissues, except for neonatal blood spots.
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Case report
PF, a female, was born in April 1997 after 39 weeks of ges-
tation from healthy, unrelated parents. Her birth weight was
2880 g, her length 49 cm, Apgar score 10 at 1 min, 10 at 5
min. Myopia was diagnosed at 6 months of age. She began
to walk at 13 months of age, and to speak at 14. In August
1998, when examined because of persistent fever and pallor,
her blood test showed: Hb 6.6 g/dl, WBC 23000/mm3 with
37% erythroblasts, platelets 40000/mm3. Her liver and spleen
were both palpable 4 cm below the costal margin, and a mod-
erate cervical lymphadenopathy was present. In her bone
marrow (BM) the erythroid component was 75% of all
nucleated cells, and blasts were 67% of non-erythroid cells.
These, resembling atypical proerythroblasts, were large with
regular round nuclei, fine lacey chromatin with nucleoli,
abundant basophil and non-granulated cytoplasm, sometimes
with blebs. They were 12% PAS+, CD34, 33, 117, 13, 45, 38
positive, with a DNA index of 1. A diagnosis of AML of the M6
FAB-type was made, and therapy was started with a standard
protocol, including idarubicin, cytosine arabinoside, and eto-
poside. Complete remission was obtained, and on 27 January
1999 the child underwent a bone marrow transplantation
(BMT) from a compatible unrelated donor: the post-transplant
course was fairly uncomplicated, and immune suppression
was discontinued 11 months after BMT. Full donor-origin
haematopoiesis and leukaemia remission were monitored by
means of cytogenetics and DNA polymorphism analysis.
In October 1999, she was re-evaluated due to the finding
of the constitutional origin of the trisomic 21 marrow clone.
She was 91 cm tall (between the 50th and 75th percentile),
weighed 14 kg (75th percentile), with a bone age of 28
months (it was 18 months at BMT, when anagraphical age
was 21 months). An accurate search failed to reveal any poss-
ible DS signs, except for monolateral epicanthal fold associa-
ted with a horizontal slant of eyes, small nose with low nasal
bridge, severe myopia ( - 10 D), overfolding upper helix with
small earlobe (Figure 1). Milestones in psychomotor develop-
ment had been reached regularly, and she was considered
normal by neuropsychiatrists. EEG, cerebral CT, and abdomen
echoscan had been performed in 1998, at AML onset, with
normal results except for organomegaly. Hand dermatogliph-
ics were not as expected in DS: the axial triradius was in t
and t9 position in the left and right hand, respectively; there
was no excess of loops on fingertips, but three arches and two
ulnar loops in the left hand, and one whirl, one arch, one
ulnar and two radial loops in the right one.
Methods
Cytogenetic studies
Chromosome analyses were performed repeatedly by routine
techniques on BM direct preparations and cultures, on PHA-
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Figure 1 The proband, aged 2 years 6 months.
stimulated peripheral blood (PB) cultures, and on fibroblast
cultures from a skin biopsy. Chromosome analysis of both par-
ents and of maternal grandparents was performed on PHA-
stimulated PB cultures. QFQ-banding technique was applied.
Fluorescent in situ hybridization (FISH) was carried out at
onset with whole chromosome paint (Vysis, Downers Grove,
IL, USA) for chromosomes 13 and 14 on BM metaphases, with
a standard procedure. On BM interphase nuclei we used chro-
mosome 7 and 8-specific alphoid centromeric probes (Vysis),
and the unique sequence probe LSI 21 (Vysis) which maps to
the chromosome region 21q22.13–21q22.2, according to the
manufacturer. In order to obtain evidence of the constitutional
trisomy 21 mosaicism, FISH analysis on interphase nuclei was
then performed with the LSI 21 probe also on PHA-stimulated
blood cells, and on skin fibroblasts. Control slides from heal-
thy subjects were concurrently used to assess the significance
of the results obtained on nuclei. All the images were obtained
through a Zeiss Axiophot 2 epifluorescence microscope (Carl
Zeiss, Jena, Germany) equipped with a CCD camera, and
analyzed by PowerGene Systems (Perceptive Scientific
Instruments, Chester, UK).
Molecular studies
Molecular studies were performed to gather information on
the parental origin of the chromosome(s) 21 involved in tetra-
somy. The loci tested, scattered along the whole chromosome,
were 10, and four more loci on different chromosomes were
tested to confirm paternity. We extracted DNA with routine
techniques from BM sampled on 27 August 1998, PB sampled
on 16 October 1998, Guthrie spots, buccal smear and urinary
sediment cells of the patient, and from her parents’ blood
samples. Genotyping of STRs (Research Genetics, Huntsville,
AL, USA) was performed by use of standard procedures. PCR
amplifications were performed in 8 ml reaction mixtures con-
taining 20 ng genomic DNA; 330 nM of each primer; 200 mM
of dCTP, dGTP, dTTP and dATP; 50 mM KCl; 10 mM TRIS pH
9; 1.5 mM MgCl2; 0.1% Triton X-100; 0.01% gelatine and 0.2
U of Taq Polymerase. The PCR conditions consisted of an
initial denaturation step followed by 30 cycles of 94 ° C for 40
s, 57 ° C for 40 s, 72 ° C for 40 s and a final extension at 72 ° C
for 5 min, using a PTC-100 thermal cycler (MJ Research, Wal-
tham, MA, USA). Four microliters of each PCR product were
resolved by electrophoresis on denaturing (7M urea) 7% poly-
acrylamide gels for 1–3 h at 30 W. Gels were fixed in 10%
methanol/acetic acid, and stained with silver nitrate 0.012 M.
Results
Table 1 summarizes the results of chromosome analyses per-
formed, and Table 2 the FISH data obtained on interphase
nuclei to detect trisomic 21 cell populations. At onset, an
abnormal clone was found in most BM mitoses, with tetra-
somy 21 and apparently interstitial deletions of chromosomes
13 and 14. Painting for these latter failed to detect material
transposed elsewhere, thus confirming the interpretation of the
derivative chromosomes as simply deleted. Interphase nuclei
analysis showed normal disomy for chromosomes 7 and 8,
whereas tetrasomy 21 was confirmed in 181 nuclei out of 215
examined (Table 2). Out of 55 mitoses analyzed three
presented with a normal karyotype, and only one with trisomy
21 (Table 1).
After remission was achieved, the BM karyotype became
normal, as was in PHA-stimulated PB cultures. Fibroblast cul-
Table 1 Results of chromosome analyses
Date Materiala Karyotype
27.08.98 BM 47,XX,+21[1]/48,XX,del(13)(q12q14),
del(14)(q22q32),+21,+21[51]/46,XX[3]
01.09.98 BM 48,XX,del(13)(q12q14),del(14)(q22q32),
+21,+21[20]/46,XX[1]
08.10.98 BM 46,XX[33]
16.10.98 PB-PHA 46,XX[67]
07.01.99 BM 47,XX,+21[2]/46,XX[17]
22.02.99 BM 46,XY[42]
12.04.99 BM 46,XY[38]
08.07.99 SF 46,XX[101]
aBM, bone marrow direct preparations and 24–48 h cultures; PB-
PHA, PHA-stimulated peripheral blood culture; SF, skin fibroblast
culture.
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21q22.13–21q22.2
Date/Materiala No. of nuclei (%) with
0 signal 1 signal 2 signals 3 signals 4 signals
27.08.98 BM — — 31 (14.4) 3 (1.4) 181 (84.2)
16.10.98 PB-PHA — — 106 (96.4) 4 (3.6) —
08.07.99 SF — 5 (0.8) 570 (95.0) 11 (1.8) 14 (2.3)
Control 1 2 (0.4) 16 (3.5) 440 (95.4) 2 (0.4) 1 (0.2)
Control 2 1 (0.2) 11 (2.4) 440 (97.1) 1 (0.2) —
Control 3 1 (0.5) 10 (4.7) 201 (94.4) 1 (0.5) —
Control 4 — 7 (3.4) 197 (94.7) 3 (1.4) 1 (0.4)
aAbbreviations as in Table 1.
tures from a skin biopsy also showed a normal karyotype
(Table 1). Trisomy 21 was found again only in two mitoses
from the BM analysis performed just before the BMT, in Janu-
ary 1999. In addition, four other cells with three chromosomes
21, but with random losses of other chromosomes, had also
been observed in the BM analysis made in October 1998.
Further interphase studies failed to reveal a trisomic 21 cell
population both in preparations from PHA-stimulated PB cul-
tures and from skin fibroblast cultures (Table 2). In fact, we
compared the results with those obtained in four healthy con-
trols, where the proportion of cells with less than two signals
was in the range 2.6–5.2%, and that of cells with more than
two signals in the range 0.2–1.8% (Table 2). Cells with two
signals consistently represented in controls at least 94.4% of
the total (Table 2). The proportion of cells with three and four
signals found in our patient’s PHA-stimulated PB and fibro-
blasts might look different from controls, but small numbers
and slightly variable results in controls are sufficient to give
this impression. To draw unbiased conclusions we compared
by chi-square the frequency of cells with more than two sig-
nals in our patient’s stimulated blood and fibroblasts with that
of control 4 (Table 2), and the differences were found not to
be significant (P , 0.25 and P , 0.10, respectively).
The chromosome analyses performed after BMT (January
1999) documented a good engraftment. The parents’ kary-
otypes were normal, as were those of maternal grandparents.
Analysis of the STRs was informative in five out of 10 tested
(Table 3): in the BM sample three loci (D21S1413, D21S1414,
Table 3 Results of microsatellite analysis on father (F), proband’s peripheral blood at remission (PB), bone marrow at onset (BM), Guthrie
spot (GS), buccal smear (BS), urinary sediment cells (US), mother (M)
Locus cM F PB BM GS BS US M
D21S1414 9.72 BD AD ACD — — — AC
D21S1437 13.05 BC AC AC — — — AA
D21S1436 13.05 AA AB AB — — — BB
D21S1250 17.67 AC AB AB — — — AB
D21S1442 24.73 AB AA AA — — — AA
D21S1270 27.40 AA AA AA — — — AA
D21S1413 29.78 AB BC ABC ABC BC BC AC
D21S2055 40.49 AB BC BCD BCD BC (A)BC CD
D21S1889 45.26 AC AA AA — — — AB
D21S1903 53.64 BC BD BD — — — AD
Informative results are shown in bold; three letters refer to the presence of three alleles, alleles of higher intensity are identified by bold
italic. The allele A of D21S2055 in brackets in the US column was interpreted as from the marrow donor.
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D21S2055) showed three alleles, two of which were of
maternal origin (Figure 2), while two loci (D21S1436,
D21S1437) showed only two alleles, with the maternal one
of higher intensity as compared to the paternal (Figure 2).
Three alleles were also seen in the DNA sample obtained from
the Guthrie spot at loci D21S1413 (Figure 2) and D21S2055.
The PB sample consistently showed two alleles without any
evident difference of intensity (Figure 2), as did the cells
obtained from buccal mucosa. Cells from the urinary sediment
showed the same two alleles as in blood at locus D21S1413,
and a third allele similar to a paternal one at locus D21S2055:
as these cells were obtained after BMT, and a small amount
of WBC is frequently present in the urinary sediment, we inter-
preted the third allele as being derived from the donor BM.
Densitometric analysis performed on the lanes of loci with
three alleles in BM, showed that the maternal allele not
present in blood was of lower intensity with respect to the
other two which appeared similar.
The same analysis at loci D21S1436 and D21S1437 on BM,
where two alleles were present, confirmed the maternal one
as being more intense.
The results obtained in STRs analysis are consistent with a
maternal meiosis I error, as is the case in the vast majority
of DS patients,7 with one crossover between D21S2055 and
D21S1889 (Table 3). As the aim of our work was not to deter-
mine if a meiosis I or II non-disjunction had taken place, the
choice of loci used was not instrumental to this issue.
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Figure 2 Results of microsatellite analyses at the five informative
loci. A, father; B, proband’s peripheral blood at remission; C, pro-
band’s bone marrow at onset; D, mother; E, Guthrie spot.
Discussion
Trisomy 21 is frequent in AML-M6. It may be regarded as the
second most frequent anomaly, after trisomy 8, as 47 out of
390 cases included in the catalogue of chromosome aber-
rations in cancer8 showed trisomy 21: it was constitutional in
10. Tetrasomy 21 is less frequent, as the same catalogue lists
five cases, four of which had a constitutional trisomy, and also
one of pentasomy 21. Tetrasomic (and pentasomic) 21 clones
are likely to originate from the trisomic ones by clonal evol-
ution, in particular, when the two cell populations coexist in
the marrow, as in the case reported here.
While studying by microsatellite analysis the parental origin
of the supernumerary chromosomes 21 in the BM of our case,
we found that three loci were consistently informative for the
presence of three alleles, and, when only two alleles were
present, one was more intense (Table 3, Figure 2). The same
uneven intensity of the two alleles was not obvious at two
other loci (D21S1250, D21S1903) (Table 3). Our finding of
two maternal alleles at least at five loci is consistent only with
the origin being a meiotic error, which took place in the
mother and led to trisomy 21 in the zygote. Then this consti-
tutional trisomy was corrected, but with the remainder of a
trisomic clone at least in BM; this gave origin to the leukaemic
clone in which tetrasomy was present, together with
additional structural anomalies. To the best of our knowledge
this is the first evidence that supernumerary chromosomes in
neoplastic clones may originate from trisomic cells of
meiotic origin.
The densitometric results obtained on STRs confirmed the
higher intensity of one band in BM for loci D21S1436 and
D21S1437, which showed only two alleles. As to loci with
three alleles, the expected result in a homogeneous cell popu-
lation, assuming a consistent origin of the tetrasomy from the
same maternal chromosome 21, was a 2:1:1 ratio. This was
not observed since two bands were evenly intense and
stronger than the other one (Figure 2). A possible explanation
is that DNA had been extracted from the whole BM sample,
where a mixed population of disomic, trisomic and tetrasomic
cells is present in proportions difficult to assess.
Our patient had to be considered a constitutional mosaic
for trisomy 21, and we tried to demonstrate trisomic cell
populations out of BM with conventional cytogenetic
methods, using approximately the same standards, as to the
number of mitoses to score, which were used to obtain evi-
dence of mosaicism in DS parents.9 We then added FISH
analysis on interphase nuclei, and microsatellite analysis on
tissues other than BM. Our efforts failed to obtain any further
evidence of trisomy 21, the only exception being the
Guthrie spot:
• PB PHA-stimulated cultures gave normal results at chromo-
some analysis (Table 1): the number of metaphases scored
was sufficient to exclude a mosaicism with at least 5% tri-
somic cells with 0.95 confidence.10 The disomy 21 was
confirmed by interphase nuclei FISH (Table 2), and by
microsatellite analysis (Table 3, Figure 2).
• Skin fibroblasts were normal at chromosome analysis (Table
1): the data shown here exclude a 3% mosaicism at 0.95
confidence level.10 Interphase study confirmed disomy 21
(Table 2).
• Buccal smear cells were found not to be trisomic at
microsatellite analysis (Table 3).
• Urinary sediment cells were normal at microsatellite analy-
sis (Table 3).
• PB cells sampled at birth, obtained from a Guthrie spot,
showed three alleles at microsatellite analysis, as in BM
(Table 3, Figure 2).
The presence of trisomy 21 in blood at birth, as indicated by
the results in Guthrie spot, has two possible interpretations.
The first one is backtracking the erythroleukaemia of our case
to birth: this possibility has already been demonstrated in
acute lymphoblastic leukaemia by Wiemels et al11 who
showed the presence of TEL-AML1 fusion in neonatal blood
from Guthrie spots of six children, who developed the disease
2 or more years later. Alternatively it is evidence of the consti-
tutional mosaicism subsequently demonstrable only in BM
(Tables 1, 3). Many cases of trisomy 21 mosaicism arise by
postzygotic loss of one chromosome 21,12 and the proportion
of disomic cells may increase with age due to the same mech-
anism.13
We re-evaluated accurately the child phenotype as to DS,
even if no suspicion of DS had ever been raised. This re-evalu-
ation took place in October 1999, when the patient was 2.
years old, and did not show an obvious DS phenotype, with
a normal physical and psychomotor development. Only a few
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possible DS signs were present at physical examination: a
small monolateral epicanthal fold, but with a horizontal slant
of eyes, small nose with low nasal bridge, and a severe
myopia, diagnosed when she was 6 months old, and now at
- 10 D level.
We provide the first evidence that Haas and Seyger’s
hypothesis3 on the meiotic origin of neoplastic clones with
trisomies is tenable, as AML-M6 in the present case arose from
marrow cells with trisomy 21 of meiotic origin. It is worthy
recalling four cases in the literature in which trisomy 21 was
detected in marrow, but also in skin fibroblasts, in pheno-
typically normal infants with a transient myeloproliferative
disorder (TMD) of the DS type.14 These were in fact consti-
tutional mosaics with the trisomy confined to some tissues,
and their TMD arose from a trisomic cell, although no mol-
ecular evidence was provided to demonstrate a meiotic origin
of the trisomy. Bhatt et al14 also reviewed 10 similar cases in
which no evidence of trisomy 21 in fibroblasts was achieved,
and suggested that some of these might also be true mosaics.
We cannot establish the frequency with which the origin of
trisomy in tumours is in fact meiotic, as no similar evidence
was available until now, but also evidence of cases in which
a meiotic origin was searched for and not found is lacking.
However, we demonstrated that a meiotic origin may take
place, and further studies on the extension of this phenom-
enon are warranted because of both theoretical and practical
implications, including reproductive genetic counselling. In
fact, we may now state that in multistep carcinogenesis the
first mutation may also be: (1) a homogeneous trisomy, as of
chromosomes 13, 18, or 21 (15); (2) a constitutional evenly
distributed trisomy mosaicism, as of chromosomes 8, 9 and
21 (15, 16); (3) a tissue-confined trisomy from meiotic error,
as of chromosome 21 in the case reported here.
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